Burt Zweigenhaft

Burt Zweigenhaft General Information

Biography

Mr. Burt Zweigenhaft served as Operating Partner at BelHealth Investment Partners. He served as Board Member at Apothecary by Design. He served as Board Member at Quick Care Pharmacy. Mr. Zweigenhaft has 30 years of experience in the specialty-biotech pharmaceutical and oncology cancer care ecosystem. Previously, Mr. Zweigenhaft was the Founder, CEO and Vice Chairman of Onco360, a national oncology pharmacy care management provider. In 2014, PharMerica acquired controlling interest in Onco360. Mr. Zweigenhaft previously served as Senior Vice President of Managed Care Sales and Marketing, Government Programs, Trade Relations and Business Development Strategies for Priority Healthcare, a publicly traded company in the specialty pharmacy sector with $2.3 billion in specialty drug revenues before being acquired by Express Scripts in 2005. Before joining Priority Healthcare, Mr. Zweigenhaft spent several years serving as a specialty pharmacy consultant to Medco, CuraScript, BioScrip and several Regional National Blue Cross Blue Shield and National Managed Care Payer programs. Mr. Zweigenhaft is a member of AMCP (American Managed Care Pharmacy), HOPA (Hematology Oncology Pharmacists Association) and ASCO (American Society of Consulting Oncologists). Mr. Zweigenhaft also serves on the Editorial Boards of several industry publications and is Editor and Chief of the Journal for Value Based Cancer Care. Mr. Zweigenhaft is also Co-Chairman and Co-Founder of the Association for Value Based Cancer Care and serves as a Board Member of and Vice President of NASP (National Association of Specialty Pharmacy) in Washington, D.C.